Home
Login
Register
Live
Users
Tag cloud
Published News
Upcoming News
Submit a new story
World Pharma News Home
»
Corporate
»
PharmaGossip: A "must read" post
->
Get all Published News delivered to your inbox!
(a free service delivered by FeedBurner)
3
Vote
PharmaGossip: A "must read" post
Posted by
PharmaGossip
294 days ago
(
http://pharmagossip.blogspot.com
)
View profile
Category
:
Corporate
|
Tags
:
pharma
Big Pharma has lost its heart and its soul.
Discuss
Add this link to...
Bury
Add to:
|
Bookmarks
Comments
Who Voted
Related Links
Comments
Log in to comment
or register
here
.
Who voted for this story
PharmaGossip
G00gle
alex
Related Links
New Initiative Trains Nurses to Manage Clinical Trials
The Largest Pharmaceutical Companies and Britain's Serious Fraud Office in the News
European Commission calls on interested parties to submit information on biocides
Avista Capital Partners to Acquire Bristol-Myers Squibb Medical Imaging for $525 Million
Amendment to Chapter 5 of the EU GMP Guide ("Qualification of Suppliers") expected in Early 2008
Pharma's Cutting Edge » A PR virus for Pharma
Pharma Marketing Blog: DocCheck® Physician Social Network Comes to US
Big Pharma on rebound after tough week - MarketWatch
eHealth News EU - The First Web 2.0 Pharmaceutical News Portal
Pharma Sector: Few Newsmakers Of The Week - Synta, Glaxo, Merck, Wyeth, Lilly, Medicis, Pipex
What is World Pharma News?
World Pharma News .net is the first worldwide Web 2.0 pharmaceutical news service developed on the top of the World Pharma News .com Project.
Login
|
Register
Top Today
1
Children in the world's poores...
Published News
1
Children in the world's poores...
2
Drug Injury Watch: Risk Of Dig...
1
New discovery: lethal fungus r...
2
UnitedHealth Takes On Microsof...
2
Goodwin: Pharma Ties Have 'Nev...
Categories
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
Top Tags
bayer
biotech
drug-injury
drug-safety
fda
glaxosmithkline
novartis
pfizer
pharma
training courses
read more
Comments